• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NEU

NEUREN PHARMACEUTICALS LIMITED

3.35% ! $19.72
Market Cap $2.413B  !

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NEU
Share Price
11:46 17K 8.7M
11:46 Last post  What A Gas Comments Created with Sketch.  17K  Views Created with Sketch.  8.7M 
NEU
M&A
3 4 5
06/12/25 298 168K
06/12/25 Last post  Pigreco314 Comments Created with Sketch.  298  Views Created with Sketch.  168K 
NEU
Acadia
28 29 30
06/12/25 1.7K 913K
06/12/25 Last post  gingerclam Comments Created with Sketch.  1.7K  Views Created with Sketch.  913K 
NEU
Pipeline-in-a-drug
3 4 5
06/12/25 250 133K
06/12/25 Last post  CullerCoded Comments Created with Sketch.  250  Views Created with Sketch.  133K 
NEU
Neuren Media and Analyst Coverage
32 33 34
05/12/25 2.0K 1.1M
05/12/25 Last post  simons77 Comments Created with Sketch.  2.0K  Views Created with Sketch.  1.1M 
NEU
Rest of world sales
03/12/25 16 5.9K
03/12/25 Last post  htae39 Comments Created with Sketch.  16  Views Created with Sketch.  5.9K 
NEU 25/11/25 66 33K
25/11/25 Last post  Innameonly Comments Created with Sketch.  66  Views Created with Sketch.  33K 
NEU 24/11/25 0 711
24/11/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  711 

See All Discussions arrow Created with Sketch.

Timeline

Application for quotation of securities - NEU
24 Nov 17:43
 
Investor Presentation, 10 November 2025
10 Nov 08:46
 
Record DAYBUE net sales of US$101.1 million in Q3 2025
06 Nov 09:59
 
Fast Track granted by FDA for NNZ-2591 in Phelan-McDermid
20 Oct 09:28
 
Change of registered office in Australia
17 Oct 16:44
 
Application for quotation of securities - NEU
03 Oct 16:58
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$19.72
Change
0.640(3.35%)
Mkt cap ! $2.413B
Open High Low Volume
$19.14 $19.81 $19.10 200.9K

Buyers (Bids)

Vol. Price($)
872 $19.60
 

Sellers (Offers)

Price($) Vol.
$19.75 404
Last trade - 16.25pm 05/12/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.